Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MELANOMA - THERAPY , . Treffer: 28

2017

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, JJ; Nathan, P; Dummer, R; Forsea, AM; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Kukushkina, M; De La Cruz Merino, L; Ymeri, A; Risteski, M; Garbe, C More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer. 2017; 75(4):313-322
Web of Science PubMed FullText FullText_MUG

 

Lallas, A; Apalla, Z; Ioannides, D; Lazaridou, E; Kyrgidis, A; Broganelli, P; Alfano, R; Zalaudek, I; Argenziano, G; International Dermoscopy Society Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society.
Br J Dermatol. 2017; 177(3):645-655
Web of Science PubMed FullText FullText_MUG

 

2016

Ribero, S; Pampena, R; Bataille, V; Moscarella, E; Thomas, L; Quaglino, P; Potenza, C; Van Akkooi, ACJ; Testori, A; Nathan, P; Puig, S; Zalaudek, I; Argenziano, G; Longo, C Unknown Primary Melanoma: Worldwide Survey on Clinical Management.
Dermatology. 2016; 232(6):704-707 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wiesner, T; Kutzner, H; Cerroni, L; Mihm, MC; Busam, KJ; Murali, R Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Pathology. 2016; 48(2):113-131 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Argenziano, G; Giacomel, J; Abramavicus, A; Pellacani, G; Longo, C; De Pace, B; Albertini, G; Cristofolini, M; Zalaudek, I Improving triage and management of patients with skin cancer: challenges and considerations for the future.
Expert Rev Anticancer Ther. 2012; 12(5):609-621
Web of Science PubMed FullText FullText_MUG

 

2011

Becker, JC; Schrama, D Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
J Invest Dermatol. 2011; 131(6):1185-1187 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Becker, JC; Burgdorf, W Janus publications -- or two sides of the same coin
J DTSCH DERMATOL GES. 2009; 7(6): 493-494.
Web of Science PubMed FullText FullText_MUG

 

Hofmann, UB; Voigt, H; Andersen, MH; Straten, PT; Becker, JC; Eggert, AO Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
Eur J Immunol. 2009; 39(5):1419-1424
Web of Science PubMed FullText FullText_MUG

 

Straten, PT; Becker, JC Adoptive cell transfer in the treatment of metastatic melanoma.
J Invest Dermatol. 2009; 129(12):2743-2745 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Giacomel, J; Zalaudek, I; Mordente, I; Nicolino, R; Argenziano, G Never perform laser treatment of skin tumors with clinical EFG criteria.
J Dtsch Dermatol Ges. 2008; 6(5):386-388 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Schrama, D; Keller, G; Schadendorf, D; Brocker, EB; Houben, R; Zapatka, M; Fink, W; Kaufman, HL; Becker, JC Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
Cancer Immunol Immunother. 2008; 57(5):685-691
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Hauschild, A; Schadendorf, D; Garbe, C; Ugurel, S; Kähler, KC New promises in the adjuvant, and palliative treatment of melanoma.
Cancer Treat Res. 2007; 135(21):277-292
PubMed

 

Wobser, M; Voigt, H; Houben, R; Eggert, AO; Freiwald, M; Kaemmerer, U; Kaempgen, E; Schrama, D; Becker, JC Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Cancer Immunol Immunother. 2007; 56(7):1017-1024
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Dejaco, C; Duftner, C; Schirmer, M Induction of tolerance in autoimmune diseases rather than cure of cancer by interleukin-2 therapy.
J Clin Oncol. 2006; 24(20): e34; author reply e35-e34; author reply e36. [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Müller-Berghaus, J; Ehlert, K; Ugurel, S; Umansky, V; Bucur, M; Schirrmacher, V; Beckhove, P; Schadendorf, D Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
Cancer Res. 2006; 66(12):5997-6001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schadendorf, D; Ugurel, S; Schuler-Thurner, B; Nestle, FO; Enk, A; Brocker, EB; Grabbe, S; Rittgen, W; Edler, L; Sucker, A; Zimpfer-Rechner, C; Berger, T; Kamarashev, J; Burg, G; Jonuleit, H; Tuttenberg, A; Becker, JC; Keikavoussi, P; Kampgen, E; Schuler, G Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Ann Oncol. 2006; 17(4):563-570 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Langmann, G; Lechner, H; Wenzel, E; Mossböck, G; Wackernagel, W Transpupillary thermotherapy (TTT) for uveal melanomas. Long term results of a single TTT with an adapter for a conventional infrared laser].
Ophthalmologe. 2005; 102(12):1162-1167
Web of Science PubMed FullText FullText_MUG

 

2004

Berger, TG; Haendle, I; Schrama, D; Luftl, M; Bauer, N; Pedersen, LO; Schuler-Thurner, B; Hohenberger, W; Straten, PT; Schuler, G; Becker, JC Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells
INT J CANCER. 2004; 111(2): 229-237. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Wolf, IH; Richtig, E; Kopera, D; Kerl, H Locoregional cutaneous metastases of malignant melanoma and their management.
Dermatol Surg. 2004; 30(2 Pt 2):244-247
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Andersen, MH; Gehl, J; Reker, S; Pedersen, LO; Becker, JC; Geertsen, P; Straten, PT Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
Semin Cancer Biol. 2003; 13(6):449-459
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Fink, W; Zimpfer, A; Ugurel, S Mucosal metastases in malignant melanoma.
Onkologie. 2003; 26(3):249-251 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Hoff, M; Rehak, P; Kapp, K; Hofmann-Wellenhof, R; Zalaudek, I; Poschauko, J; Uggowitzer, M; Kohek, P; Smolle, J Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma.
J Dtsch Dermatol Ges. 2003; 1(8):635-642
PubMed Google Scholar

 

2002

Wack, C; Kirst, A; Becker, JC; Lutz, WK; Brocker, EB; Fischer, WH Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Cancer Immunol Immunother. 2002; 51(8):431-439
Web of Science PubMed FullText FullText_MUG

 

1998

Lode, HN; Xiang, R; Becker, JC; Gillies, SD; Reisfeld, RA Immunocytokines: a promising approach to cancer immunotherapy.
Pharmacol Ther. 1998; 80(3):277-292
Web of Science PubMed FullText FullText_MUG

 

Terheyden, P; Kampgen, E; Runger, TM; Brocker, EB; Becker, JC Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature
Hautarzt. 1998; 49(10):770-773 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

BROCKER, EB; BECKER, JC Immunology of melanoma
HAUTARZT. 1995; 46(11): 818-828.
Web of Science PubMed Google Scholar

 

1992

BECKER, JC; DUMMER, R; SCHWINN, A; HARTMANN, AA; BURG, G Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy.
J Immunother (1991). 1992; 12(2):147-150
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1976

KERL, H Diagnosis, pathology and therapy of malignant melanoma of the skin (author's transl)
WIEN KLIN WOCHENSCHR. 1976; 88(12): 369-379.
Web of Science PubMed

 

© Med Uni Graz Impressum